BioCryst Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on BioCryst Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date BioCryst Pharmaceuticals Inc Strategy Report
- Understand BioCryst Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on BioCryst Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 22 Nov 2021 | BioCryst Pharma Raises USD350 Million in Private Financing | Private Equity |
Royalty Pharma Plc
OMERS Capital Markets
|
BioCryst Pharmaceuticals Inc |
| 01 Jun 2021 | BioCryst Pharmaceuticals Inc Enters Phase III Clinical Trial Agreement with AMS Advanced Medical Services GmbH for berotralstat hydrochloride (GDCT0421427) | Contract Service Agreement |
BioCryst Pharmaceuticals Inc
|
AMS Advanced Medical Services GmbH
|
| 28 May 2021 | BioCryst Pharmaceuticals Inc Enters Phase III Clinical Trial Agreement with Novotech Australia Pty Ltd for berotralstat hydrochloride (GDCT0421427) | Contract Service Agreement |
BioCryst Pharmaceuticals Inc
|
Novotech Australia Pty Ltd
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer